Aptus Pharma Limited Share Price

Aptus Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing a range of medicine solutions which include Anti-Infectives, Antacids and PPI, G.I. Medicines, Anti-Allergic and Respiratory Medicine, Nutritional Supplements, Anti-Inflammatory and Pain Management, Neuro-Psychiatric Medicine, Lipid Lowering Medicine, Anti-Hypertensives and Cardiovascular Medicine, Antidiabetic Medicine, and Consumer Care. Its divisions include Aptus Pharma, Aptus CD Care, Aptus WellCare, and Aptus Global. Its brands include Chilkul, Koltus, Telbira, and Aptirub. Its products include APBILE-150, APBILE-300, APORA 5 CREAM, APTICHYM-FORTE, APTIDA-10, APTIDA-M, APTIDOL-MR, APTIDOX-L, APTIFRESH, APTIFRESH-EC, APTIFRESH-FM, APTIFRESH-LE, APTIFRESH-MD, APTIFRESH-MW, APTIGLIM-M1 FORTE, APTIGLIM-M1 PR, APTIGLIM-M2 FORTE, APTIGLIM-M2 SR, among others.As of 25 May 2026, Aptus Pharma Limited share price is ₹179.50. The stock opened at ₹181.50, compared to its previous close of ₹182.00. During today's trading session, Aptus Pharma Limited share price moved in the range of ₹179.50 to ₹181.50, with an average price of ₹180.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹179.50 and a high of ₹181.50.

The market capitalization of Aptus Pharma Limited is ₹312 Crs and a dividend yield of 0.00%.